The Hazardous Drugs: Best Practice for Nurses and Healthcare Institutions was held at the Wellcome Collection, London on April 21st 2023, attended by Clinical Governance Directors, Cancer Services Directors, Lead Cancer Nurses, Pharmacists and healthcare policy makers from across the… Read more

New EU guidance on handling Hazardous Medicinal Products (HMPs) includes the following areas where there is a risk of occupational exposure: • Manufacturing • Reception and unpacking • Transport and storage • Preparation in pharmacies, healthcare and veterinary facilities •… Read more

Ian Lindsley, Secretary of the European Biosafety Network, gave a presentation to the conference of the International Society of Oncology Pharmacy Practitioners, ISOPP 2023, in Seville on 3 March entitled ‘Is your pharmacy ready for EU legislation?’ He spoke about… Read more

On 12 October, from 11-12h, CET, the ETUI is hosting a webinar on cancer risks in healthcare workers: identification of Hazardous Medicinal Products (HMPs). In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous… Read more

Ian Lindsley, Secretary of the EBN, attended the 18th Seminar on workers’ protection and chemicals in Zadar, Croatia from 28-29 June 2022. The seminar was organised by the European Trade Union Institute (ETUI) and is financially supported by the European… Read more

22nd June 2022. Summary The webinar, chaired by Ian Lindsley, Secretary of the European Biosafety, was well-attended with over 50 attendees and strong engagement from participants. After welcoming attendees, Mr Lindsley talked through the agenda of the webinar and set… Read more

On 22nd June 2022, the European Biosafety Network, in partnership with the Directorate-General for Health and Food Safety (DG SANTE) and the International Organisation for Standardisation (ISO), will host an online webinar on the prevention of sharps injuries and the… Read more

A consortium led by RPA is developing a Guidance document for the safe management of hazardous medicinal products at work (HMPs), under contract to the European Commission’s Directorate-General for Employment, Social Affairs and Inclusion (DG EMPL). The aim of the document… Read more

The Roundtable (25/03/2022), chaired by Gitta Vanpeborgh, Belgian Federal Deputy, was well-attended with strong engagement from participants. Hanne Sanders, Adviser on Wellbeing and Safety at Work to Cabinet of the Deputy Prime Minister and Ministry of the Economy and Labour… Read more

The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and hazardous medicinal products (HMPs) in the fourth… Read more